Evidence map›Paper›PMID 40137809›Full record

ArticleSports (Basel, Switzerland)2025

Novel Use of Generalizability Theory to Optimize Countermovement Jump Data Collection.

Alan Huebner, Jonathon R Lever, Thomas W Clark, Timothy J Suchomel, Casey J Metoyer, Jonathan D Hauenstein, John P Wagle

Abstract read
In one paragraph

Article in Sports (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alan HuebnerSports Performance, University of Notre Dame, Notre Dame, IN 46556, USA.ORCID 0000-0003-2141-5793
Jonathon R LeverSports Performance, University of Notre Dame, Notre Dame, IN 46556, USA.ORCID 0009-0000-1167-7795
Thomas W ClarkDepartment of Applied and Computational Mathematics and Statistics, University of Notre Dame, Notre Dame, IN 46556, USA.ORCID 0009-0000-3560-6166
Timothy J SuchomelDepartment of Sports Medicine and Nutrition, University of Pittsburgh, Pittsburgh, PA 15260, USA.ORCID 0000-0002-1763-5518
Casey J MetoyerSports Performance, University of Notre Dame, Notre Dame, IN 46556, USA.
Jonathan D HauensteinDepartment of Applied and Computational Mathematics and Statistics, University of Notre Dame, Notre Dame, IN 46556, USA.ORCID 0000-0002-9252-8210
John P WagleSports Performance, University of Notre Dame, Notre Dame, IN 46556, USA.ORCID 0000-0003-4508-4271

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to evaluate the reliability of countermovement jump (CMJ) performance metrics across five NCAA Division I varsity sports using Generalizability Theory (G-Theory). Three hundred male athletes from football, hockey, baseball, soccer, and lacrosse performed three or more CMJs on dual-force platforms. G-Theory was applied to identify variance components and determine reliability coefficients (Φ) for 14 key metrics. Metrics requiring more than three jumps to achieve Φ 0.80 were deemed unreliable. Metric reliability varied by sport and phase of movement. Metrics associated with the eccentric phase (e.g., Eccentric Duration, Deceleration Rate of Force Development Asymmetry) demonstrated lower reliability, often requiring >3 jumps. Reliable metrics across sports included Phase 1 Concentric Impulse and Scaled Power, requiring three trials or fewer. CMJ reliability is sport- and metric-specific. Practitioners should prioritize reliable metrics and adjust protocols to balance data quality and practicality, particularly when monitoring eccentric characteristics.

Indexed as

CMJforce platemonitoringteam sporttesting

Identifiers

PMID40137809
PMCPMC11945484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.